Sign in or register to see full information and data.

Studies / CAVD 643

Overview

Study information

Network:CAVD
Grant Affiliation:Haynes: B cell Lineage Envelope Design from RV144 Antibodies
Strategy:Combo: Protein & vector vaccines
Study Type:Antibody Screening
Species:Non-Organism Study
Stage:Assays Completed
Study Start Date:2017-03-22
Study Made Public:NA

Title

Assaying Ig containing memory B cell culture supernatants for autologous tier 2 neutralization

Description

CAVD 643 is a monoclonal antibody screening study evaluating broadly neutralizing antibodies from RV306 vaccinees.

Products

ALVAC (vCP1521) AIDSVAX B/E Placebo ALVAC Placebo AIDSVAX B/E

Integrated data

No integrated data is available for this study.

Non-integrated data

No non-integrated data is available for this study.